In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin

Biochimica et Biophysica Acta - General Subjects

Volumn 1725, Issue 2, 2005, Pages 145-151

  Ratanaphan, Adisorn ^a   Canyuk, Bhutorn ^a   Wasiksiri, Siriwat ^a   Mahasawat, Pawika ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

BRCA1; Carboplatin; Gel electrophoresis; QPCR

Indexed keywords

AGAROSE; CARBOPLATIN; CISPLATIN; DNA; MESSENGER RNA; NUCLEOTIDE;

3' UNTRANSLATED REGION; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EXON; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; LEUKOCYTE; ONCOGENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANTINEOPLASTIC AGENTS; BRCA1 PROTEIN; BREAST NEOPLASMS; CARBOPLATIN; CELL LINE, TUMOR; DNA ADDUCTS; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ORGANOPLATINUM COMPOUNDS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 24344459455     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2005.07.006     Document Type: Article

References (38)

1. C.A. Lepre, and S.J. Lippard Interaction of platinum antitumor compounds with DNA F. Eckstein D.M.J. Lilley Nucleic Acids and Molecular Biology 1990 Springer Heidelberg 9 38
2. J. Reedijk Improved understanding in platinum antitumour chemistry Chem. Commun. 1996 801 806
3. A.M.J. Fichtinger-Schepman, J.L. van der Veer, J.H.J. den Hartog, P.H.M. Loman, and J. Reedijk Adducts of the antitumor drug cis-diamminedichloroplatinum (II) with DNA: formation, identification and quantitation Biochemistry 24 1985 707 713
4. A.C.M. Plooy, M. van Dijk, and P.H.M. Lohman Induction and repair of DNA cross-links in CHO cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity and antitumor activity Cancer Res. 44 1984 2043 2051
5. B.A. Donahue, M. Augot, S.F. Bellon, D.K. Treiber, J.H. Toney, S.J. Lippard, and J.M. Essigmann Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin Biochemistry 29 1990 5872 5880
6. A.M.J. Fichtinger-Schepman, R.A. Baan, A. Luiten-Schuite, M. van Dijk, and P.H.M. Lohman Immunochemical quantitation of adducts induced in DNA by cis- diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding Chem.-Biol. Interact. 55 1985 275 288
7. A.H. Calvert, S.J. Harland, D.R. Newell, Z.H. Siddik, A.C. Jones, T.J. McElwain, S. Raju, E. Wiltshaw, I.E. Smith, J.M. Baker, M.J. Peckham, and K.R. Harrap Early clinical studies with cis-diammine-1,1-cyclobutanedicarboxylate platinum (II) Cancer Chemother. Pharmacol. 9 1982 140 147
8. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, T. Tran, M. McClure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, K. Yakumo, Z. Gholami, D. Shaffer, S. Stone, S. Bayer, C. Wray, R. Borgden, P. Dayananth, J. Ward, P. Tonin, S. Narod, P. Bristow, F. Norris, L. Helvering, P. Morrision, P. Roseteck, M. Lai, J.C. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R.W. Wiseman, A. Kamb, and M.H. Skolnick A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
9. L.C. Wu, Z.W. Wang, J.T. Tsan, M.A. Spillman, A. Phung, X.L. Xu, M.C.W. Yang, L.Y. Hwang, A.M. Bowcock, and R. Baer Identification of a RING protein that can interact in vivo with Brca1 gene product Nat. Genet. 14 1996 430 440
10. J.M. Meza, P.S. Brzovic, M.C. King, and R.E. Klevit Mapping the functional domains of BRCA1: interaction of the ring finger domains of BRCA1 and BARD1 J. Biol. Chem. 274 1999 5659 5665
11. P.L. Welcsh, K.N. Owens, and M.C. King Insights into the functions of BRCA1 and BRCA2 Trends Genet. 16 2000 69 74
12. J.A. Rodriquez, and B.R. Henderson Identification of a functional nuclear export sequence in BRCA1 J. Biol. Chem. 275 2000 38589 38596
13. M.S. Chapman, and I.M. Verma Transcriptional activation by BRCA1 Nature 382 1996 678 679
14. A.N.A. Monteiro, A. August, and H. Hanafusa Evidence for a transcriptional activation function of BRCA1 C-terminal region Proc. Natl. Acad. Sci. U. S. A. 93 1996 13595 13599
15. I. Callebaut, and J.P. Marnon From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair FEBS Lett. 400 1997 25 30
16. L.C. Gowen, A.V. Avrutskaya, A.M. Latour, B.H. Koller, and S.A. Leadon BRCA1 required for transcription-coupled repair of oxidative DNA damage Science 281 1998 1009 1012
17. X. Yu, L.C. Wu, A.M. Bowcock, A. Aronheim, and R. Baer The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtlP, a protein implicated in the CtBP pathway of transcriptional repression J. Biol. Chem. 273 1998 25388 25392
18. Y. Chen, W.H. Lee, and H.K. Chew Emerging Role of BRCA1 in Transcriptional regulation and DNA repair J. Cell. Physiol. 191 1999 385 395
19. T. Miyake, Y.F. Hu, D.S. Yu, and R. Li A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling J. Biol. Chem. 275 2000 40169 40173
20. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
21. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from nucleated cells Nucleic Acids Res. 16 1988 1215
22. H.L. Govan, Y. Valles-Ayoub, and J. Braun Fine-mapping of DNA damage and repair in specific genomic segments Nucleic Acids Res. 18 1990 3823 3830
23. D.P. Kalinowski, S. Illenyne, and B. van Houten Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay Nucleic Acids Res. 20 1992 3485 3494
24. M.M. Jennerwein, and A. Eastman A polymerase chain reaction-based method to detect cisplatin adducts in specific genes Nucleic Acids Res. 19 1991 6209 6214
25. K.A. Grimadi, J.P. Bingham, R.L. Souhami, and J.A. Hartley DNA damage by anticancer agents and its repair: mapping in cells at the subgene level with quantitative polymerase chain reaction Anal. Biochem. 222 1994 236 242
26. S.H. Yuh, M. Tibudan, and P. Hentosh Analysis of 2-chloro-2′- deoxyadenosine incorporation into cellular DNA by quantitative polymerase chain reaction Anal. Biochem. 262 1998 1 8
27. M. Honma, M. Hayshi, P. Hackman, and T. Sofuni Chlorambucil-induced structural changes in the gpt gene of AS 52 cells Mutat. Res., Toxicol. Environ. Mutagen. 389 1997 199 205
28. 6-alkylating agents in vitro Gene Ther. 5 1998 835 841
29. M.J. Tilby, C. Johnson, R.J. Knox, J. Cordell, J.J. Roberts, and C.J. Dean Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody Cancer Res. 51 1991 123 129
30. K.C. Micetich, D. Barnes, and L.C. Erickson A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutane- dicarboxylato)platinum (II) on L1210 cells Cancer Res. 45 1985 4043 4047
31. F.A. Blommaert, H.C.M. van Dijk-Knijnenburg, F.J. Dijt, L. den Engelse, R.A. Baan, F. Berends, and A.M.J. Fichtinger-Schepman Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells Biochemistry 34 1995 8474 8480
32. S.E. Sherman, and S.J. Lippard Structural aspects of platinum anticancer drug interactions with DNA Chem. Rev. 87 1987 1153 1181
33. R.J. Knox, F. Friedlos, D.A. Lydall, and J.J. Roberts Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis- diamminedichloroplatinum (II) and cis- diammine (1,1-cyclobutanedicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA Cancer Res. 46 1986 1972 1979
34. 2(CBDCA-O)(5′-GMP-N7)] in solution Inorg. Chem. 32 1993 1333 1340
35. I. Gill, F.M. Muggia, P.M. Terheggen, C. Michael, R.J. Parker, V. Kortes, S. Grunberg, M.C. Christian, E. Reed, and L. den Engelse Dose-escalation study of caeboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum-DNA adducts Ann. Oncol. 2 1991 115 121
36. F.A. Blommaert, C. Michael, P.M. Terheggen, F.M. Muggia, V. Kortes, J.H. Schornagel, A.A.M. Hart, and L. den Engelse Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response Cancer Res. 53 1993 5669 5675
37. M.A. Jakupec, M. Galanski, and B.K. Keppler Tumor-inhibiting platinum complexes-State of the art and future perspectives Rev. Physiol., Biochem. Pharmacol. 146 2003 1 53
38. L.B. Travis, R.E. Curtis, H. Strom, P. Hall, E. Holowaty, F.E. van Leeuwen, B.A. Kohler, E. Pukkala, C.F. Lynch, M. Anderson, K. Bergfeldt, E.A. Clarke, T. Wiklund, G. Stoter, M. Gospodarowicz, J. Sturgeon, J.F. Fraumeni Jr., and J.D. Boice Jr. Risk of second malignant neoplasms among long-term survivors of testicular cancer J. Natl. Cancer Inst. 89 1997 1429 1439